Effect of silodosin on intraurethral pressure increase induced by hypogastric nerve stimulation in dogs with benign prostatic hyperplasia

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Yoshitaka TomiyamaNobuo Shibata

Abstract

We compared the urethral and cardiovascular effects of silodosin (selective alpha(1A)-adrenoceptor antagonist), a novel medication for benign prostatic hyperplasia (BPH), with those of tamsulosin (selective alpha(1A)/alpha(1D)-adrenoceptor antagonist) and naftopidil (selective alpha(1D)-adrenoceptor antagonist). We evaluated the effects of these three drugs on the increase in intraurethral pressure (IUP) induced by electrical stimulation of the hypogastric nerve in anesthetized dogs with spontaneous BPH. All three drugs dose-dependently reduced both the increase in IUP and the mean blood pressure (MBP). The rank order of potencies was tamsulosin>silodosin>naftopidil for the reductions in both IUP and MBP. However, the uroselectivity (ED(15) value for hypotensive effect/ID(50) value for reduction in IUP) of silodosin (uroselectivity, 19.8) was about 21 and 4 times higher than that of tamsulosin (0.939) and naftopidil (4.94), respectively. These data suggest that silodosin might be one of the most useful medications for dysuria in BPH patients.

References

Sep 1, 1990·Veterinary Pathology·L A LowsethB A Muggenburg
May 1, 1980·The American Journal of Medicine·J D Wilson
Jul 1, 1995·British Journal of Pharmacology·I MarshallC R Chapple
May 2, 2001·Journal of the American Veterinary Medical Association·K SirinarumitrM A Memon

❮ Previous
Next ❯

Citations

Nov 29, 2007·Expert Opinion on Investigational Drugs·Masaki YoshidaKazuki Kawabe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.